Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00673881

ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study

ABT-335 (Choline Fenofibrate)Reverse Cholesterol Transport (RCT) Study

Sponsor: Radiant Research

Updated 6 times since 2017 Last updated: Mar 25, 2011 Started: Mar 31, 2008 Primary completion: May 31, 2009 Completion: May 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Dyslipidemia and is currently completed. Radiant Research leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1_PHASE2

First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Radiant Research

Data source: Radiant Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States